HEPAR-P Study

CCRE Therapeutics is providing data management for the HEPAR-P Study, a study being conducted by the Malaysian Liver Foundation.  The HEPAR-P Study is a randomised double-blind placebo-controlled trial of an anti-viral phytopharmaceutical for chronic Hepatitis B infection.  The study is being conducted in Malaysia, and the CCRE Therapeutics Data Centre is providing a range of clinical data management services including development of case record forms for fax receipt of data, patient randomisation and enrolment via IVRS (Interactive Voice Response System), and data collection and management.